Journal
CELLS
Volume 10, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/cells10092380
Keywords
Alzheimer's; amyloid; bioenergetics; mitochondria; prohibitin; proteomics
Categories
Ask authors/readers for more resources
This study revealed that Aβ(42) disrupts proteome responses for signaling, bioenergetics, and morphology in mitochondria. These findings highlight the specific components of the mitochondrial response during Aβ(42) neurotoxicity and suggest several new biomarkers for detection and surveillance of amyloid disease.
Alzheimer's disease (AD) is marked by chronic neurodegeneration associated with the occurrence of plaques containing amyloid beta (A beta) proteins in various parts of the human brain. An increase in several A beta fragments is well documented in patients with AD and anti-amyloid targeting is an emerging area of therapy. Soluble A beta can bind to various cell surface and intracellular molecules with the pathogenic A beta(42) fragment leading to neurotoxicity. Here we examined the effect of A beta(42) on network adaptations in the proteome of nerve growth factor (NGF) differentiated PC12 cells using liquid-chromatography electrospray ionization mass spectrometry (LC-ESI MS/MS) proteomics. Whole-cell peptide mass fingerprinting was coupled to bioinformatic gene set enrichment analysis (GSEA) in order to identify differentially represented proteins and related gene ontology (GO) pathways within A beta(42) treated cells. Our results underscore a role for A beta(42) in disrupting proteome responses for signaling, bioenergetics, and morphology in mitochondria. These findings highlight the specific components of the mitochondrial response during A beta(42) neurotoxicity and suggest several new biomarkers for detection and surveillance of amyloid disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available